163 related articles for article (PubMed ID: 9145960)
1. The immunohistochemical characteristics of the basosquamous cell carcinoma.
Jones MS; Helm KF; Maloney ME
Dermatol Surg; 1997 Mar; 23(3):181-4. PubMed ID: 9145960
[TBL] [Abstract][Full Text] [Related]
2. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.
Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011
[TBL] [Abstract][Full Text] [Related]
3. Reappraising basosquamous carcinoma: a summary of histologic features, diagnosis, and treatment.
Shukla S; Khachemoune A
Arch Dermatol Res; 2020 Nov; 312(9):605-609. PubMed ID: 32166375
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants.
Mitsuhashi T; Itoh T; Shimizu Y; Ban S; Ogawa F; Hirose T; Shimizu M
J Cutan Pathol; 2006 Mar; 33(3):246-52. PubMed ID: 16466514
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
6. Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers.
Bellizzi AM; Woodford RL; Moskaluk CA; Jones DR; Kozower BD; Stelow EB
Am J Surg Pathol; 2009 Nov; 33(11):1608-14. PubMed ID: 19738459
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal.
Webb DV; Mentrikoski MJ; Verduin L; Brill LB; Wick MR
Ann Diagn Pathol; 2015 Apr; 19(2):70-5. PubMed ID: 25702956
[TBL] [Abstract][Full Text] [Related]
8. Marjolin's ulcer: immunohistochemical study of 17 cases and comparison with common squamous cell carcinoma and basal cell carcinoma.
Kim JM; Su WP; Kurtin PJ; Ziesmer S
J Cutan Pathol; 1992 Aug; 19(4):278-85. PubMed ID: 1385500
[TBL] [Abstract][Full Text] [Related]
9. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
10. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.
Tope WD; Nowfar-Rad M; Kist DA
Dermatol Surg; 2000 May; 26(5):415-8. PubMed ID: 10816226
[TBL] [Abstract][Full Text] [Related]
11. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection.
Gill P; Naugler C; Abi Daoud MS
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953
[TBL] [Abstract][Full Text] [Related]
12. BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.
Linskey KR; Gimbel DC; Zukerberg LR; Duncan LM; Sadow PM; Nazarian RM
Arch Pathol Lab Med; 2013 Nov; 137(11):1591-8. PubMed ID: 24168496
[TBL] [Abstract][Full Text] [Related]
13. Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases.
Winters R; Naud S; Evans MF; Trotman W; Kasznica P; Elhosseiny A
Head Neck Pathol; 2008 Dec; 2(4):265-71. PubMed ID: 20614292
[TBL] [Abstract][Full Text] [Related]
14. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
Beer TW; Shepherd P; Theaker JM
Histopathology; 2000 Sep; 37(3):218-23. PubMed ID: 10971697
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
Kazantseva IA; Khlebnikova AN; Babaev VR
Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors.
Franz R; Ritter N; Hein R; Biedermann T; Al-Sisi M; Eyerich K; Garzorz-Stark N; Andres C
Am J Dermatopathol; 2017 Oct; 39(10):742-746. PubMed ID: 28857981
[TBL] [Abstract][Full Text] [Related]
17. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.
Sarbia M; Loberg C; Wolter M; Arjumand J; Heep H; Reifenberger G; Gabbert HE
Am J Pathol; 1999 Oct; 155(4):1027-32. PubMed ID: 10514383
[TBL] [Abstract][Full Text] [Related]
19. A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck.
Villada G; Kryvenko ON; Campuzano-Zuluaga G; Kovacs C; Chapman J; Gomez-Fernandez C
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):126-131. PubMed ID: 27438511
[TBL] [Abstract][Full Text] [Related]
20. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation.
Kist D; Perkins W; Christ S; Zachary CB
Dermatol Surg; 1997 Nov; 23(11):1067-70. PubMed ID: 9391566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
